EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model

Manal Moustafa Mahmoud iD, Laila Ahmed Rashed iD, Somia Abdulatif Soliman iD, Safaa Mostafa Sayed, Omneya Kamel, Samaa Samir Kamar iD, Rania El Sayed Hussien iD

Physiological Reports · 2023

DOI: 10.14814/phy2.15858 ↗

At a glance

Journal article in Physiological Reports, 2023. Written by Manal Moustafa Mahmoud and 6 co-authors. Institution: Department of Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt. Major MEDLINE topics: Metformin, Polycystic Ovary Syndrome, Sodium-Glucose Transporter 2 Inhibitors, Insulin Resistance. Cited 14 times so far (Crossref); 97 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Polycystic ovary syndrome (PCOS) is a common endocrine, reproductive, and metabolic disorder affecting females. The management of PCOS is challenging and current interventions are not enough to deal with all consequences of this syndrome. We explored the beneficial effect of combined sodium glucose co transporter‐2 inhibitor (SGLT‐2i); (empagliflozin) and metformin on hormonal and metabolic parameters in an animal model of PCOS and insulin resistance (IR). Forty adult female Wistar rats divided into five groups: control, PCOS‐IR, PCOS‐IR treated with metformin, PCOS‐IR treated with empagliflozin, and PCOS‐IR treated with combined metformin and empagliflozin. Single modality treatment with metformin or empagliflozin yielded significant improvement in body mass index, insulin resistance, lipid profile, sex hormones, inflammatory markers, and ovarian cystic follicles. Combined metformin with empagliflozin expressed further significant improvement in sex hormones, inflammatory markers with disappearance of ovarian cystic follicles. The superior significant improvement with combined treatment over the single modality was in line with significant improvement in the ovarian AMPKα‐SIRT1 expression.

Subjects

MeSH terms (MEDLINE)

MetforminPolycystic Ovary SyndromeSodium-Glucose Transporter 2 InhibitorsInsulin ResistanceHumansRatsFemaleAnimalsRats, WistarInsulinGonadal Steroid HormonesBenzhydryl CompoundsGlucosides

Author keywords

AMPKα-SIRT1PCOSempagliflozininsulin resistancemetformin

Substances

MetforminSodium-Glucose Transporter 2 InhibitorsInsulinGonadal Steroid HormonesempagliflozinBenzhydryl CompoundsGlucosides

Authors and institutions

  • Department of Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Biochemistry Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Physiology, School of Medicine, New Giza University, Cairo, Egypt.
  • Department of Histology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Histology, Armed Forces College of Medicine, Cairo, Egypt.

ORCID profiles: Manal Moustafa Mahmoud, Laila Ahmed Rashed, Somia Abdulatif Soliman, Samaa Samir Kamar, Rania El Sayed Hussien

Cite

APA

Mahmoud, M. M., Rashed, L. A., Soliman, S. A., Sayed, S. M., Kamel, O., Kamar, S. S., & Hussien, R. E. S. (2023). SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model. Physiological Reports. https://doi.org/10.14814/phy2.15858

Vancouver

Mahmoud MM, Rashed LA, Soliman SA, Sayed SM, Kamel O, Kamar SS, et al. SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model. Physiological Reports. 2023. doi:10.14814/phy2.15858

BibTeX
@article{Mahmoud2023,
  author = {Mahmoud, Manal Moustafa and Rashed, Laila Ahmed and Soliman, Somia Abdulatif and Sayed, Safaa Mostafa and Kamel, Omneya and Kamar, Samaa Samir and Hussien, Rania El Sayed},
  title = {SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model},
  journal = {Physiological Reports},
  year = {2023},
  doi = {10.14814/phy2.15858}
}
Start for free →